Gastrointestinal

The Pharmacy Times® Gastrointestinal resource center provides news and articles centered around the FDA approved drugs in gastroenterology, as well as links to condition-specific resources, and videos and other content.

What can we help you find?
[[thumbnail_alt_text]]
Opioid-Induced Constipation: Conversations With HCPs
Shared insight on the open dialogues that should take place between patients with opioid-induced constipation and care providers.
[[thumbnail_alt_text]]
Goals of Managing OIC & Prophylactic Strategies
Key opinion leaders provide their perspectives on the goals of therapy and prophylactic management of opioid-induced constipation.
[[thumbnail_alt_text]]
Opioid-Induced Constipation: Diagnosis & Treatment Guidelines
A comprehensive review of opioid-induced constipation diagnosis strategies and foundational treatment guidelines.
[[thumbnail_alt_text]]
Opioid-Induced Constipation: Pathophysiology & Disease Burden
A panel of experts considers the disease pathology of opioid-induced constipation and the burden it has on patients.
[[thumbnail_alt_text]]
Company Halts Ranitidine Production Over NDMA Contamination Concerns
After some lots of ranitidine were found to contain small amounts of N-nitrosodimethylamine (NDMA), Novartis's Sandoz unit has announced that they are halting distribution of ranitidine (Zantac) products until the contamination concerns are resolved.
[[thumbnail_alt_text]]
FDA Approves New Packaging for OTC Loperamide Products
Officials from the FDA have announced an approved package size and package type limit for over-the-counter (OTC) brand-name tablet and capsule forms of loperamide.
 
[[thumbnail_alt_text]]
Probable Carcinogen Found in Samples of Ranitidine
An over-the-counter and prescription drug, ranitidine is an H2 (histamine-2) blocker that decreases the amount of acid created by the stomach.
[[thumbnail_alt_text]]
Cornering Constipation, Making Motility a Priority
A major reason patients visit their primary care providers is constipation. Often, the constipation is acute and prescribers can identify an underlying cause and correct it. Even more often, there is no underlying cause and the patient is diagnosed with chronic idiopathic constipation (CIC).
[[thumbnail_alt_text]]
Manage Diarrhea With the Right Products
Health care professionals can play an important role in managing patients with diarrhea by recommending OTC products for initial treatment.
[[thumbnail_alt_text]]
Identify How and When to Treat Dyspepsia and Heartburn
Pharmacists are instrumental in guiding patients on the appropriate and safe use of products for gastrointestinal discomfort.
[[thumbnail_alt_text]]
Constipation Frustrates Patients and Providers
Just 22% of those who suffer seek help from a health care provider, newer agents show promise.
[[thumbnail_alt_text]]
Counsel Patients With GERD About Certain Foods
Diet and lifestyle changes are key components of treating gastroesophageal reflux disease.

The Pharmacy Times® Gastrointestinal resource center provides a source of all the latest clinical information, with articles covering updates from the robust pipeline of novel GI therapies, and the newest data from all phases of clinical trials and studies in the space. It also serves as a hub of information and news from the upcoming and ongoing conferences and annual meetings of gastrointestinal associations and societies, including pivotal coverage right from the floor.

Among its other resources are a wealth of videos including interviews with thought leaders and experts in GI, and moderated Peer Exchange panel discussions about the best practices and key methods for treating complex cases of conditions such as: constipation, irritable bowel syndrome, hemorrhoids, anal fissures, perianal abscesses, anal fistulas, perianal infections, diverticular diseases, colitis, colon polyps and cancer.